U. Westin, å. Polling, I. Ljungkrantz, K. Ohlsson
Identification of SLPI (Secretory Leukocyte Protease
Inhibitor) in Human Mast Cells Using Immunohistochemistry and
In Situ Hybridisation
Recently interest has been focused on secretory leucocyte protease inhibitor (SLPI) and its role in immediate hypersensitive reactions, possibly by inhibiting mast cell chymase. The purpose of this investigation was to show whether or not SLPI is produced in mast cells.
Double-immunolabelling revealed that SLPI coexists with mast cell tryptase (60%) and chymase (37%). On the other hand, in situ hybridisation studies demonstrated the expression of SLPI mRNA in all mast cells. The differences in results can be attributed to the fact that in situ hybridisation is a more sensitive method than immunohistochemistry. Hence, we conclude that SLPI is produced in human tonsillar mast cells.
Biological Chemistry, Walter de Gruyter
Print ISSN: 1431-6730
Volume: 380, 04/1999
Pages: 489 - 493
Show full article (external site)
Show all available items of this journal